Invagen Pharmaceuticals, Inc. - Net Worth and Insider Trading
Invagen Pharmaceuticals, Inc. Net Worth
The estimated net worth of Invagen Pharmaceuticals, Inc. is at least $0 dollars as of 2024-05-30. Invagen Pharmaceuticals, Inc. is the 10% Owner of Avenue Therapeutics Inc and owns about 0 shares of Avenue Therapeutics Inc (ATXI) stock worth over $0. Details can be seen in Invagen Pharmaceuticals, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Invagen Pharmaceuticals, Inc. has not made any transactions after 2022-10-11 and currently still holds the listed stock(s).
Transaction Summary of Invagen Pharmaceuticals, Inc.
Invagen Pharmaceuticals, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Invagen Pharmaceuticals, Inc. owns 1 companies in total, including Avenue Therapeutics Inc (ATXI) .
Click here to see the complete history of Invagen Pharmaceuticals, Inc.’s form 4 insider trades.
Insider Ownership Summary of Invagen Pharmaceuticals, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2022-10-11 | 10 percent owner |
Invagen Pharmaceuticals, Inc. Latest Holdings Summary
Invagen Pharmaceuticals, Inc. currently owns a total of 1 stock. Invagen Pharmaceuticals, Inc. owns 0 shares of Avenue Therapeutics Inc (ATXI) as of October 11, 2022, with a value of $0.
Latest Holdings of Invagen Pharmaceuticals, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2022-10-11 | 0 | 3.72 | 0 |
Holding Weightings of Invagen Pharmaceuticals, Inc.
Invagen Pharmaceuticals, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Invagen Pharmaceuticals, Inc. has made a total of 1 transactions in Avenue Therapeutics Inc (ATXI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Avenue Therapeutics Inc is the sale of 5,185 shares on October 11, 2022, which brought Invagen Pharmaceuticals, Inc. around $3 Million.
Insider Trading History of Invagen Pharmaceuticals, Inc.
- 1
Invagen Pharmaceuticals, Inc. Trading Performance
Invagen Pharmaceuticals, Inc. Ownership Network
Invagen Pharmaceuticals, Inc. Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
Invagen Pharmaceuticals, Inc. is the 10 percent owner of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , Chief Executive Officer Alexandra Maclean , and Int. PEO & Int. PFO & and COO David Jin .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, Invagen Pharmaceuticals, Inc. made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .
In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,228 shares were bought by its insiders, resulting in a net purchase of 2,001 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
Invagen Pharmaceuticals, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Invagen Pharmaceuticals, Inc.. You might contact Invagen Pharmaceuticals, Inc. via mailing address: Site B, 7 Oser Ave., Hauppauge Ny 11788.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
